More on CLRB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.58 |
|
|||
| Open | $2.52 | ||||
| 52 Wk High | $6.03 | ||||
| 52 Wk Low | $0.41 | ||||
| Day High | $2.59 | ||||
| Day Low | $2.47 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 50,487 | ||||
- Cellectar publishes Phase 1 data on iopofosine I 131 in myeloma patients
- Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
- Brookline Capital Markets Reinstates Cellectar Biosciences (CLRB) at Buy
- Form 4/A Cellectar Biosciences, For: Jul 08 Filed by: Loren Stefan
- Form 8-K Cellectar Biosciences, For: Jul 07
- Form 4 Cellectar Biosciences, For: Jul 07 Filed by: Kolean Chad J
- Form 4 Cellectar Biosciences, For: Jul 07 Filed by: DRISCOLL FREDERICK W
- Form 4 Cellectar Biosciences, For: Jul 07 Filed by: Chanan-Khan Asher
- Form 4 Cellectar Biosciences, For: Jul 07 Filed by: CARUSO JAMES V
- Form 4 Cellectar Biosciences, For: Jul 07 Filed by: Gu Andrew
Entities mentioned with CLRB
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- S1 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
